The benefits of the Johnson & Johnson coronavirus vaccine outweigh any potential risks, according to the Centers for Disease Control and Prevention.
The big picture: There have been 7.8 cases of Guillain-Barre syndrome, a rare neurological disorder, per million doses among adults, which is higher than expected in the general population, according to CDC data.
Get market news worthy of your time with Axios Markets. Subscribe for free.
By comparison, there has been about one case of Guillain-Barre per million doses for people who received either of the two-dose mRNA vaccines, according to the agency.
The data comes a little over a week after the Food and Drug Administration added a warning to the Johnson & Johnson coronavirus vaccine, saying the shot can lead to an increased risk of a rare neurological condition.
Driving the news: Despite the small risk of an adverse reaction to the shot, the Johnson & Johnson vaccine prevents against the vast majority of death and serious illness from coronavirus.
"Many hospitalizations, ICU admissions and deaths can be prevented through Janssen and mRNA Covid-19 vaccines, far outweighing the risks," CDC researcher Dr. Hannah Rosenblum told the agency's Advisory Committee on Immunization Practices in a meeting on Thursday, per CNN.
Between the lines: The CDC data show that for women ages 18 to 29, the vaccine would prevent 8,900 cases of coronavirus and five COVID-19 deaths and only one GBS case might occur.
For men in that age group, 6,600 COVID-19 cases and three COVID-19 deaths would be prevented and only two GBS cases might occur.
For every million doses administered among women ages 30 to 49, the data suggest 10,100 COVID-19 cases and 20 COVID-19 deaths could be prevented compared with the risk of about six to seven GBS cases.
For men in that age group, 7,600 COVID-19 cases and 25 COVID-19 deaths could be prevented compared with the risk of about seven to eight GBS cases.
For every million doses administered among women ages 50 to 64, the data suggest 12,100 COVID-19 cases and 120 COVID-19 deaths could be prevented compared with the risk of seven to eight GBS cases.
Among men, the vaccine would prevent about 10,100 Covid-19 cases and 140 Covid-19 deaths and come with the risk of between 14 to 17 GBS cases, according to the CDC data.
Like this article? Get more from Axios and subscribe to Axios Markets for free.